Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

11d ago

ESPR

PremiumPress Releases

Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

17d ago

ESPR

PremiumPress Releases

Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference

23d ago

ESPR

PremiumPress Releases

Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & Industry Expert Theatre to be Presented at ACC.24

24d ago

ESPR

PremiumPress Releases

U.S. FDA Approves Broad New Labels for NEXLETOL® and NEXLIZET® to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use

27d ago

ESPR

PremiumPress Releases

CHMP Issues Positive Opinions For Both Bempedoic Acid And The Bempedoic Acid / Ezetimibe Fixed-Dose Combination Tablet As Treatments For Hypercholesterolemia And Significantly Reducing Cardiovascular Events

27d ago

ESPR

PremiumPress Releases

Esperion Reports Fourth Quarter and Full Year 2023 Financial Results

2M ago

ESPR

More ESPR News >

0IIM News on the Web

2024-04-10

Understanding Serge Belanger’s Buy Rating for Esperion (ESPR): A Critical Analysis

TipRanks News

Neutral

2024-04-07

Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity

Yahoo Finance

Bullish

2024-04-01

Esperion to Ring Nasdaq Opening Bell Today, April 1, 2024

Yahoo Finance

Bullish

2024-03-28

Does Esperion Therapeutics Inc (ESPR) Have What it Takes to be in Your Portfolio Thursday?

Investors Observer

Neutral

2024-03-28

Why Is Esperion Therapeutics Up 2% Since Last Earnings Report?

Yahoo Finance

Neutral

2024-03-28

Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?

Zacks

Neutral

2024-03-27

Do Traders Think Esperion Therapeutics Inc (ESPR) Can Keep Climbing Wednesday?

Investors Observer

Neutral

2024-03-26

Esperion to Participate in 23rd Annual Needham Virtual Healthcare Conference

Yahoo Finance

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GB:0IIM’s Media Buzz Sentiment?

Currently, no data Available

What is GB:0IIM’s weekly average amount of articles?

Currently, no data Available

What is GB:0IIM’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

ELVElevance Health

CGEMCullinan Management

EWEdwards Lifesciences

MRNSMarinus

INSPInspire Medical Systems

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing